Increased mesolimbic dopamine binding following chronic haloperidol treatment

Area of Science:

• Neuroscience
• Pharmacology
• Neurobiology

Background:

• Chronic neuroleptic treatment is known to induce dopamine receptor supersensitivity in the striatum.
• The mesolimbic pathway's dopamine receptor sensitivity following neuroleptic exposure requires further investigation.

Purpose of the Study:

• To investigate the impact of chronic haloperidol and phenobarbital administration on dopamine receptor binding in the rat septum.
• To determine if neuroleptic-induced dopamine receptor supersensitivity extends to the mesolimbic system.

Main Methods:

• Rats were administered daily injections of haloperidol (0.5 mg/kg), sodium phenobarbital (50 mg/kg), or saline for 21 days.
• Following a one-week washout period, septal tissue was collected for a tritium-labeled dopamine ([3H]-dopamine) binding assay.

Main Results:

• Haloperidol treatment led to a significant 52% increase in [3H]-dopamine binding in the septum.
• Phenobarbital treatment did not produce any significant alterations in dopamine receptor binding within the septum.

Conclusions:

• Chronic haloperidol administration induces dopamine receptor supersensitivity in the rat mesolimbic system (septum).
• The findings suggest that different neuroleptic agents may have varying effects on dopamine receptor sensitivity in distinct brain regions.